Home AboutMedia & News Papers & Research Membership Contacts

News

Bring cryo-EM into your focus

Image Description

2024-03-01

Cell Cover | Shuimubio Aids in Deciphering Chloroplast Gene Transcription Machinery

Image Description

2023-02-08

In Silico Discovery of Small Molecule Modulators Targeting the Achilles' Heel of SARS-CoV-2 Spike Protein

Image Description

2023-01-20

Preprint: Cryo-EM structure of DNA polymerase θ helicase domain in complex with inhibitor novobiocin

Image Description

2022-09-08

Enrollment List | TOP25 of the 2<SUP>nd</SUP> Young Scientist Cryo-EM Research Support Program

Image Description

2022-08-18

Preprint: Cryo-EM complex structure of active GPR75 with a nanobody

Image Description

2022-07-25

2<SUP>nd</SUP> Young Scientist Cryo-EM Research Support Program

Image Description

2022-04-08

Shuimu will hold booth#2013 during the AACR 2022 event

Image Description

2022-03-04

Cryo-EM enabled novel and highly differentiated antibody development

Image Description

2022-03-21

Serial entrepreneur Allen Guo: go beyond boundaries

Image Description

2022-02-26

NEXT TECH opens, shuimu helps French pharmaceutical companies to innovate in China

Image Description

2022-02-25

Shuimu, Biocytogen and others collaborate to publish new research paper on COVID19-neutralizing antibody in Cell Discovery

Image Description

2022-02-25

The second 300kV cryo-EM up and running, apply for Krios G4 free trial now

Send us a message

Connect with Us. Make Great Things Happen Together.

To inquire about our services, simply fill out this form and we'll be in touch.

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Quick Links

Home About Media Resources

Services

Tomography Cryo-EM SPA

Cryo-EM Characterization Data Collection Protein Production MicroED

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2024 Shuimu Biosciences Ltd.